| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | 1 | — | — | 3 | — | 4 | — | — | 2 | — |
| total | individual payouts | |
|---|---|---|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 42.86 | 37.14 | 45.29 | 39.80 |
| Receivables | 104.69 | 109.72 | 124.44 | 146.92 |
| Inventory | 199.20 | 196.99 | 182.79 | 191.71 |
| Other | 202.81 | 224.24 | 273.47 | 283.01 |
| 549.57 | 568.09 | 625.98 | 661.44 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 72.27 | 75.78 | 74.65 | 95.58 |
| ST’ Debt | 7.81 | 12.50 | 5.00 | 5.00 |
| Other | 53.49 | 34.45 | 40.69 | 56.40 |
| 183.70 | 175.50 | 179.24 | 196.98 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 209.02 | 224.49 | — | — |
—
|
| ’25 | 192.48 | 200.80 | 212.56 | 219.00 |
824.84
|
| ’24 | 190.85 | 197.00 | 201.41 | 197.18 |
786.44
|
| ’23 | 181.19 | 187.32 | 196.25 | 192.23 |
756.99
|
| ’22 | 163.48 | 174.20 | 186.59 | 188.27 |
712.54
|
| ’21 | 157.15 | 160.19 | 163.23 | 164.84 |
645.41
|
| ’20 | 173.48 | 147.31 | 150.37 | 157.79 |
628.94
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 11.24 | 33.55 | — | — |
—
|
| ’25 | 0.77 | 22.41 | 18.10 | (74.69) |
(33.40)
|
| ’24 | (1.65) | 3.46 | 13.94 | 18.42 |
34.18
|
| ’23 | (18.93) | 9.18 | 14.32 | 26.50 |
31.07
|
| ’22 | (18.85) | 24.97 | (5.49) | 32.05 |
32.68
|
| ’21 | (23.35) | 5.54 | 5.55 | 11.71 |
(0.56)
|
| ’20 | (12.03) | 8.64 | 4.91 | 11.09 |
12.61
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 8.35 | 30.02 | — | — |
—
|
| ’25 | (4.04) | 20.22 | 16.05 | (78.76) |
(46.53)
|
| ’24 | (6.62) | 0.14 | 11.95 | 14.80 |
20.27
|
| ’23 | (24.29) | 3.62 | 9.61 | 23.01 |
11.95
|
| ’22 | (23.62) | 20.73 | (10.78) | 26.76 |
13.07
|
| ’21 | (27.90) | 3.24 | 2.14 | 5.64 |
(16.87)
|
| ’20 | (15.90) | 7.51 | 1.68 | 6.82 |
0.11
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.64 | 1.31 | — | — |
—
|
| ’25 | 0.69 | 0.82 | (4.30) | 0.48 |
(2.27)
|
| ’24 | 0.46 | 0.52 | 0.67 | 0.45 |
2.10
|
| ’23 | 0.42 | 0.17 | 0.22 | 0.34 |
1.14
|
| ’22 | 0.66 | 0.34 | 0.69 | 0.65 |
2.33
|
| ’21 | 0.55 | 0.69 | 0.78 | 9.05 |
11.06
|
| ’20 | 0.67 | 0.43 | 0.54 | 0.80 |
2.45
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.89 | 40.24 | 47.53 | 51.76 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 58.18 | 58.28 | 70.50 | 101.47 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,465 | 2,265 | 2,180 | 2,130 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.29 | 0.33 | 0.36 | 0.39 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 712.54 | 756.99 | 786.44 | 824.84 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.25% | 21.56% | 25.08% | 26.87% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.32 | 16.38 | 26.92 | (47.25) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.68% | 2.16% | 3.42% | (5.73%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.79 | 15.93 | 21.68 | (37.35) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.42 | 32.57 | 33.44 | 33.66 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.01 | 55.19 | 53.23 | 55.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 2.38 | 1.16 | 2.13 | (2.27) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.71 | 2.26 | 2.31 | (2.24) | ‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.62) | (1.39) | (0.94) | (0.88) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.08 | 0.87 | 1.37 | (3.11) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 43.56 | 46.37 | 46.04 | 44.27 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.07 | 13.72 | 14.77 | 14.94 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.72 | 44.29 | 29.75 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.84 | 0.95 | 1.20 | 1.72 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.14 | 1.13 | 1.38 | 2.15 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.12 | 1.24 | 1.46 | 2.04 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.07 | 78.56 | 56.51 | (36.11) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.68 | 31.07 | 34.18 | (33.40) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (19.61) | (19.12) | (13.91) | (13.12) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.07 | 11.95 | 20.27 | (46.53) | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 327.90 | 365.87 | 392.59 | 446.75 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 246.85 | 264.77 | 242.33 | 303.79 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 200.60 | 221.91 | 205.19 | 258.50 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 525.96 | 636.09 | 680.12 | 661.48 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.88% | 1.49% | 1.93% | (3.23%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.42% | 2.11% | 2.98% | (2.43%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.75% | 2.74% | 3.29% | (5.57%) | — | — | — |
ROE
|
Ducommun Incorporated (DCO), a vital supplier of structural and electronic components to Boeing and Lockheed Martin, has delivered steady revenue growth—up 43% from 2016 to $787 million in 2024—fueled by defense spending surges amid geopolitical tensions and post-COVID recovery. Efficiency shines through, with revenue per employee doubling and gross margins expanding to 25%, but profitability remains volatile, marked by a 2021 peak from one-offs and a projected 2025 net loss of $31 million before a sharp rebound to $75 million by 2027. A fortified balance sheet, with debt down 24% and equity up 222%, underpins cash flow stabilization, positioning DCO for projected 10% revenue CAGR through 2027.
Yet, as shares trade near highs with modest analyst targets implying just 1-6% upside, caution prevails: Boeing’s 737 MAX delays and 30-40% commercial aero exposure cap potential, echoing past troughs that preceded 300% rallies. Insider selling is negligible, but the 2025 earnings dip—potentially a buying window—tests resolve amid thin EBT margins vulnerable to supply snarls and inflation. For contrarians eyeing defense upcycles akin to post-9/11, DCO offers hold appeal with 20-30% annualized returns possible if execution holds, but dips below targets scream opportunity.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.